tm logo
Trademark Search
CHINOOK THERAPEUTICS

View On IC.GC.CA

CHINOOK THERAPEUTICS
ADVERTISED

on 29 Nov 2024

Last Applicant/ Owned by

Chinook Therapeutics, Inc., a Delaware corporation

400 Fairview Ave North 9th FloorSeattle, WA 98109

US

Serial Number

2080923 filed on 29th Jan 2021

Registration Number

TMA1272343 registered on 29th Nov 2024

Registration expiry Date

29th Nov 2034

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

CHINOOK THERAPEUTICS

Trademark usage description

medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, therapeutic agents for use in the prevention and treatment of kidney, rena Read More

Classification Information

Class [005]
Medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, therapeutic agents for use in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; biologic preparations for prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; biological tissue cultures for medical purposes.

Classification kind code

11

Class [042]
Scientific research and development services for the identification of medicines, drugs, therapeutic pharmaceuticals, pharmaceutical preparations, therapeutic agents for use in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; product research and development in the field of pharmaceuticals; pharmaceutical research and development; conducting clinical trials; providing scientific research information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; hosting a website providing information in the field of medical and scientific research, product development, product testing in relation to prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; hosting a website providing information in the field of medical and scientific research, product development, product testing in the field of pharmaceuticals; hosting a website providing information about investigational medical diagnostics and drugs in relation to prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; hosting a website providing educational information in the field of clinical research in relation to prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of pharmaceuticals; hosting a web site featuring medical information in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions.

Classification kind code

11

Class [044]
Providing information relating to the diagnostic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing medical information in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; providing health information to patients in the field of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.

Classification kind code

11

Mark Details

Serial Number

2080923

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 27
on 19th Aug 2024		Approval Notice Sent
Submitted for opposition 26
on 19th Aug 2024		Approved
Submitted for opposition 22
on 03rd Jul 2024		Search Recorded
Submitted for opposition 20
on 03rd Jul 2024		Examiner's First Report
Submitted for opposition 48
on 22nd Feb 2024		Agent Changed
Submitted for opposition 287
on 13th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 135
on 25th Apr 2022		Amendment to Application
Submitted for opposition 30
on 29th Jan 2021		Filed
Submitted for opposition 1
on 29th Jan 2021		Created
Submitted for opposition 31
on 29th Jan 2021		Formalized